San Francisco, CA - Despite the fact that more than half of those receiving cardiac devices are obese, researchers have found that these patients are at increased risk of major complications. He noted ...

Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

Researchers analyzed the surgery outcomes of 1,386 patients who underwent a device extraction procedure due to infection at Cleveland Clinic between August 1996 and September 2012. Of this patient ...

A new Mayo Clinic study questions the benefit of implantable cardioverter-defibrillator use to treat patients with transthyretin cardiac amyloidosis. For patients with transthyretin cardiac ...

Elutia Inc. has announced the launch of a clinical study for EluPro™, the first FDA-cleared antibiotic-eluting bioenvelope designed for use with cardiac implantable electronic devices (CIEDs). This ...

While physical activity is recommended for patients with heart disease who have a pacemaker or an implantable cardioverter-defibrillator (ICD), it requires choosing the right device and programming to ...

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...